HIV/AIDS Clinical Trials in Los Angeles

Showing 1-20 of 641 trials

RECRUITINGNA< 1 mile

Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults

NCT06444360

The use of behavioral intervention to reduce stimulant use and concurrent HIV sexual transmission risk.

HIV

Westat360 participantsStarted Nov 2025

Los Angeles, California, United States • Providence, Rhode Island, United States

Active Not RecruitingPhase 3< 1 mile

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy

NCT06333808

The goal of this clinical study is to learn more about the effects of switching to the study drugs, bictegravir (BIC)/lenacapavir (LEN), fixed-dose combination (FDC) versus current therapy bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) FDC in people living with HIV-1 (PWH). The primary objective of this study is to learn how effective it is to switch to BIC/LEN FDC tablets versus continuing on B/F/TAF FDC tablets in virologically suppressed PWH.

HIV-1-infection

Gilead Sciences577 participantsStarted Mar 2024

Phoenix, Arizona, United States • Berkeley, California, United States • Beverly Hills, California, United States +101 more locations

Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy

HIV/AIDS Trials in Other Cities

A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)

Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected Adults

Mobile Enhanced Prevention Support for People Leaving Jail

Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex With Men and Are At Risk of HIV-1 Infection

Cefixime Clinical Trial

A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection

Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

Entre Herman@s: Promoting Health Among Latino MSM

Digital Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in YTW

Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer

Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas

A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV

Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC

Study of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants With Both Chronic Hepatitis B and HIV

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection

Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIV

Other Conditions in Los Angeles